Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 215 clinical trials
CCCG Relapsed Acute Lymphoblastic Leukemia 2017 Study in Children

Adding bortezomid in the relapsed chemotherapy protocol may increase the toxicity and even treatment related mortality. In this protocol, we suggested to add during the Consolidation after the induction therapy.

flow cytometry
cns involvement
bortezomib injection
pediatric
remission
  • 0 views
  • 19 Feb, 2024
  • 1 location
Ethosuximide and Pentoxifylline in the Treatment of Abdominal Pain Related to Irritable Bowel Syndrome

Ethosuximide and pentoxifylline in the treatment of abdominal pain related to irritable bowel syndrome

abdominal pain
stomach pain
mebeverine
irritable bowel syndrome
  • 0 views
  • 19 Feb, 2024
  • 1 location
Effect of Bismuth Add-on to Dual Therapy for Helicobacter Pylori Eradication

This study aims to compare the efficacy and safety of a bismuth-supplemented 14-day vonoprazan-based dual therapy ( triple therapy) versus a 14-day vonoprazan-based dual therapy without bismuth for first-line H. pylori eradication. Furthermore, the investigators will investigate the impact of these eradication regimens on the gut microbiota, the development of …

  • 0 views
  • 08 May, 2026
Randomised Evaluation of COVID-19 Therapy

RECOVERY is a randomised trial investigating whether treatment with either Lopinavir-Ritonavir, Hydroxychloroquine, Corticosteroids, Azithromycin, Convalescent plasma or Tocilizumab prevents death in patients with COVID-19.

immunoglobulin
lopinavir
immunoglobulins
acute respiratory syndrome (sars)
lopinavir/ritonavir
  • 0 views
  • 19 Feb, 2024
  • 1 location
Treating Sleep in Teens With ADHD

Sleep problems are common in adolescence and recognized as an international public health concern given their links to a range of adverse outcomes. Adolescents with attention-deficit/hyperactivity disorder (ADHD) experience more sleep problems than their peers, including delayed sleep onset, shorter sleep duration, poorer sleep quality, more sleep variability, and greater …

sleepiness
deficit
adhd
somnolence
anxiety
  • 0 views
  • 19 Feb, 2024
  • 1 location
Multi Neuro-functional Biomarkers for Monitoring the Effects of Treatments in ADHD Children

MIMOSA study aims to characterize from behavioral, neurophysiological and neurocognitive perspectives children and adolescents with attention deficit hyperactivity disorder (ADHD), in order to identify a possible biomarker of response to medication treatments. To achieve this aim, in the study children with ADHD (drug naive) are recruited and undergo behavioral and …

hyperactivity
attention deficit disorder
deficit
methylphenidate
psychiatric disorder
  • 0 views
  • 19 Feb, 2024
  • 1 location
Effectiveness of a Mobile Neurofeedback for ADHD Youth

Objective: Verification of ADHD Treatment Effectiveness of Mobile Neurofeedback to Subjects of Child and Youth with ADHD. Method: Mobile Neurofeedback Program is implemented for 165 ADHD patients aged 8 to 15 to verify their effectiveness by conducting pre-post evaluation.

neurofeedback
attention deficit hyperactivity disorder
neuropsychological test
sham treatment
methylphenidate
  • 0 views
  • 19 Feb, 2024
  • 1 location
Short Structured Psychological Intervention for Adults With ADHD - a Randomized Controlled Trial

The main objective is to evaluate whether SAINT will show better outcomes on measures of ADHD-related symptoms, everyday function, and quality-of-life measures, when compared to the self-help material, and if any possible differences in outcomes are related to better treatment adherence in SAINT.

substance use
psychiatric symptoms
stimulant
cns stimulants
attention deficit hyperactivity disorder
  • 0 views
  • 19 Feb, 2024
  • 1 location
Nigella Sativa in COVID-19

If encouraging outcomes occurred, NS supplementation may be recommended as an add-on to standard care protocol to enhance the recovery from COVID-19 disease in the current emerging situation.

SARS
pneumonia
covid-19
antiviral drugs
respiratory infection
  • 0 views
  • 19 Feb, 2024
  • 1 location
Doxapram Therapy in Preterm Infants (DOXA Trial)

Doxapram is a respiratory stimulant that has been administered off-label to treat AOP. Doxapram, as add-on treatment, seems to be effective in treating AOP and to prevent invasive mechanical ventilation. It is unclear if a preterm infant benefit from doxapram treatment on the longer term.

off-label
mechanical ventilation
pulmonary disease
lung disease
nervous
  • 0 views
  • 19 Feb, 2024
  • 18 locations